Introduction {#s1}
============

Inflammation is a double-edged sword of the innate immune response. To limit the undesirable consequences of excessive inflammation, factors that modulate the initiation phase and the resolution phase of inflammation can determine the nature of the inflammatory response ([@B1]). The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that was initially recognized as a receptor mediating the pathologic effects of dioxins and other pollutants ([@B2]). Recent studies have identified the molecular functions of AhR in the immune system during steady state and during infection and inflammation ([@B3]--[@B6]). AhR was shown to be involved in LPS-induced inflammatory gene expression ([@B7]). AhR-KO mice were hypersensitive to LPS-induced septic shock, mainly as a result of macrophage dysfunction. Consistent with their enhanced susceptibility to LPS treatment, AhR-KO mice showed markedly increased plasma levels of IL-1β, IL-18, IL-6, and

TNF-α ([@B8]). Activated AhR also played a central role in limiting endotoxin-triggered inflammation, resulting in the establishment of endotoxin tolerance ([@B9]).

Inflammatory responses mediated by macrophages are part of the innate immune system ([@B10]). Macrophages are important effector cells of innate immunity, with a pivotal role in host defense against intracellular pathogens ([@B11]). The roles of AhR in the differentiation and function of specific T-cell subpopulations and B cells in adaptive immune response are well known ([@B4]). However, although numerous studies have addressed the modulatory effect of AhR in innate immune cells, such as dendritic cells (DCs), neutrophils and natural killer cells ([@B12]), the exact role of AhR in macrophage function remains to be elucidated. Increasing evidences have also demonstrated roles for AhR in the regulation of inflammation and inflammatory cytokines. AhR negatively regulated IL-6 production in macrophages following LPS stimulation ([@B13], [@B14]). AhR activation also inhibited caspase-1 activation and subsequent IL-1β secretion in macrophages ([@B15]). IL-10 is an immunoregulatory cytokine with a crucial role in ameliorating immunopathology and preventing inflammatory responses, which leads us to hypothesize that AhR may also regulate IL-10 expression in inflammatory macrophages in innate immunity.

IL-10 is an important anti-inflammatory cytokine, and understanding how its expression is critical to designing immune-intervention strategies ([@B16]). IL-10 production is regulated by various transcription factors and signaling pathways. Src kinases are a family of nine non-receptor tyrosine kinases involved in the induction of IL-10 ([@B17], [@B18]). Acute alcohol exposure activates many transcription factors via the Src kinase family to promote IL-10 production in human monocytes ([@B19]). STAT3 is an important regulator of LPS-induced IL-10 gene expression ([@B20]) and has been shown to bind to intron 4 of the IL-10 gene and drive its production ([@B21]). Notably, STAT3 activation also occurs downstream of the IL-10 receptor ([@B22]), and IL-10 positively regulates its own production in an autocrine manner via activation of STAT3 ([@B23]). It is therefore necessary to determine if feed-forward IL-10 loop exists in the study. Furthermore, several studies have shown that activation of MAPK ([@B24], [@B25]) and the PI(3)K-AKT-mTOR pathways ([@B26]) are critical for the production of IL-10 by macrophages.

Previous reports revealed that AhR function was mediated by both genomic and non-genomic pathways. The AhR canonical pathway that is also called as AhR genomic pathway is characterized by AhR nuclear translocation. In the absence of a ligand, AhR is present in the cytoplasm in a complex with several chaperone proteins, including heat shock protein 90 (HSP90), p23, X-associated protein 2, and AhR associated protein 9. Upon ligand binding, AhR translocates into the nucleus, where it is released from the complex, heterodimerizes with its protein partner AhR nuclear translocator (ARNT), and finally binds to genomic regions inducing transcription of its target genes ([@B3], [@B27]). However, in addition to this classical AhR genomic pathway, the AhR also has been shown to regulate gene expression through non-genomic signaling pathways ([@B4], [@B28]). Several studies reported that 2,3,7,8-tetrachlorodibenzo p-dioxin (TCDD) induced inflammatory responses through a non-genomic AhR function ([@B29], [@B30]). In the absence of ligand activation, AhR could control cellular processes along with other transcriptional factors in the cytoplasm ([@B9], [@B13], [@B28]). It is therefore necessary to determine if the above pathways are involved in the regulation of IL-10 expression by AhR.

In this study, we investigated LPS-induced AhR expression in various macrophages and its role in IL-10 expression. We examined the mechanisms responsible for LPS-stimulated IL-10 production in macrophages from AhR-KO mice and AhR-overexpressing RAW264.7 cells, and showed that it was associated with Src and STAT3 activation, but was not regulated via the AhR genomic pathway. These results identified the AhR-Src-STAT3 pathway as a critical signaling pathway in the production of IL-10 by inflammatory macrophages, thus providing an innovative platform for future studies of the mechanisms of AhR in immune regulation.

Results {#s2}
=======

AhR is increased in LPS-stimulated macrophages via NF-κB pathway
----------------------------------------------------------------

AhR was previously reported to be highly expressed in T cells stimulated by TGF-β plus IL-6 ([@B31]) and in LPS-induced bone marrow derived DCs ([@B32]) and human DCs ([@B33]). In this study, we investigated the expression of AhR in LPS-stimulated mouse macrophages, which were identified according to the dual presence of F4/80 and CD11b (Figure [S1](#SM1){ref-type="supplementary-material"}). LPS increased AhR expression in peritoneal macrophages, bone marrow derived macrophages (BMDMs) and spleen macrophages (Figure [1A](#F1){ref-type="fig"}). AhR mRNA levels of peritoneal macrophages were increased at 1 h after LPS treatment, reached a peak at 2 h, and then gradually decreased (Figure [1B](#F1){ref-type="fig"}). Consistent with the mRNA data, AhR protein expression levels were increased at 2 h after LPS stimulation, increased rapidly up to 12 h, and peaked at 8 h (Figures [1C,D](#F1){ref-type="fig"}). However, LPS had no significant effect on expression of the AhR chaperone proteins ARNT and HSP90 (Figure [1C](#F1){ref-type="fig"}). Immunofluorescence assay confirmed that AhR protein expression was enhanced at 6 and 8 h after LPS stimulation (Figure [1E](#F1){ref-type="fig"}). Given that activated NF-κB is a critical component regulating the expression of AhR ([@B33]), we examined AhR expression in the presence of the NF-κB inhibitor pyrrolidinedithiocarbamate (PDTC). Peritoneal macrophages were pretreated with PDTC for 1 h, and the inhibitory effect was confirmed by reduced translocation of p65 and p50 into the nucleus after NF-κB activation. The LPS-stimulated AhR expression was disturbed by pretreatment with PDTC (Figure [1F](#F1){ref-type="fig"}). These results supported the hypothesis that LPS-induced AhR expression was mediated by the NF-κB pathway in macrophages.

![AhR was increased in LPS-stimulated macrophages via the NF-κB pathway. **(A)** Peritoneal macrophages, BMDMs, and spleen macrophages isolated from C57BL/6J mice were treated with or without LPS (10 μg/ml) for 8 h. Then, the cells were lysed and subjected to western blotting analysis of AhR protein expression. **(B--E)** Peritoneal macrophages were treated with or without LPS (10 μg/ml) for the indicated times. **(B)** AhR mRNA levels were detected with qRT-PCR. The experiment was repeated three times; combined results are compared using one-way ANOVA test (2 h: control, *P* \< 0.001; 4 h, control; *P* \< 0.001; 6 h, control; *P* \< 0.001; 8 h, control; *P* = 0.004). **(C)** Protein expression levels of AhR, ARNT, and HSP90 were analyzed with western blotting. **(D)** Quantitative analysis of the AhR expression measured in **(C)**. The experiment was repeated four times; combined results are compared using one-way ANOVA test (2 h: control, *P* \< 0.001; 4 h: control, *P* \< 0.001; 6 h: control, *P* \< 0.001; 8 h: control, *P* = 0.004). **(E)** AhR protein expression was also assessed with immunofluorescence. Cells were immunostained with AhR-specific antibody (red) and co-stained with DAPI (blue) to detect nuclei. Bar, 20 μm. **(F)** Peritoneal macrophages were pre-treated with PDTC for 1 h and then stimulated with LPS for 8 h. AhR protein expression was analyzed by western blotting. The experiment was repeated three times; combined results are compared using one-way ANOVA test (LPS: LPS+PDTC, *P* = 0.013). Western blots and immunofluorescence images are representative of three independent experiments. Data shown as mean ± SEM of at least three independent experiments. Differences were analyzed with one-way ANOVA. ^\*^*P* \< 0.05.](fimmu-09-02033-g0001){#F1}

Loss of AhR in macrophages results in reduced IL-10 expression after LPS stimulation
------------------------------------------------------------------------------------

AhR downregulated IL-6 ([@B13], [@B14]) and IL-1β ([@B15]) expression in inflammatory macrophages in line with our current findings (Figure [S2](#SM2){ref-type="supplementary-material"}). Because AhR acted as a negative regulator of TLR signaling pathway, we speculated that AhR was positively correlated with IL-10 expression in LPS-induced macrophages. AhR expression levels in AhR-KO cells were greatly reduced compared with WT cells (Figures [2A,B](#F2){ref-type="fig"}). We also compared LPS-induced IL-10 expression in WT and AhR-KO macrophages, and IL-10 mRNA levels were reduced in peritoneal macrophages from AhR-KO mice compared with WT mice at 4 h after LPS stimulation (Figure [2C](#F2){ref-type="fig"}). Levels of IL-10 protein in the culture medium of LPS-induced AhR-KO peritoneal macrophages were lower than that of LPS-induced WT cells (Figure [2E](#F2){ref-type="fig"}). Furthermore, BMDMs from AhR-KO mice produced less IL-10 mRNA (Figure [2D](#F2){ref-type="fig"}) and IL-10 protein (Figure [2F](#F2){ref-type="fig"}) in response to LPS compared with BMDMs from WT mice. These results suggested that AhR expression was positively correlated with IL-10 expression in inflammatory macrophages.

![Loss of AhR in macrophages reduced IL-10 expression after LPS stimulation. Peritoneal macrophages and BMDMs isolated from WT or AhR-KO mice were stimulated with or without LPS at the indicated time points. **(A,B)** Whole-cell lysates were subjected to western blotting analysis with anti-AhR antibody. **(C,D)** IL-10 mRNA levels were detected with qRT-PCR at 4 h after LPS stimulation. The experiment was repeated three times; combined results are compared using one-way ANOVA test (PMs, *P* \< 0.001; BMDMs, *P* \< 0.001). **(E,F)** Supernatants were collected at 12 h after LPS stimulation and IL-10 production was measured with ELISA. The experiment was repeated six times; combined results are compared using one-way ANOVA test (PMs, *P* \< 0.001; BMDMs, *P* = 0.003). Western blots images are representative of three independent experiments. Data in all bar graphs are mean ± SEM of three independent experiments. Differences were analyzed by one-way ANOVA. ^\*^*P* \< 0.05.](fimmu-09-02033-g0002){#F2}

AhR upregulated LPS-induced IL-10 expression in RAW264.7 cells independent of AhR genomic pathway
-------------------------------------------------------------------------------------------------

To study the regulatory effect of AhR on LPS-stimulated IL-10 expression, we established a stable AhR-overexpressing RAW264.7 murine macrophage cell line. The infection efficacy was confirmed by expression of labeled Flag protein and GFP in the RAW/AhR cells (Figure [3A](#F3){ref-type="fig"}). Gene and protein expression levels of AhR were significantly upregulated in RAW/AhR cells compared with RAW/normal control (NC) or RAW cells (Figures [3A,B](#F3){ref-type="fig"}). Consistent with the AhR-KO data, AhR promoted the expression of IL-10 mRNA at different time points, with a peak at 4 h after LPS treatment (Figure [3C](#F3){ref-type="fig"}). IL-10 protein levels were higher in the LPS-induced RAW/AhR cells compared with the LPS-induced RAW/NC cells (Figure [3D](#F3){ref-type="fig"}). To determine if the regulation of IL-10 expression was dependent on the AhR genomic pathway, we treated the macrophages with AhR ligands and confirmed their activity by measuring the cytochrome P4501A expression of AhR target gene. The mRNA levels of CYP1A1 were increased by AhR agonists, such as TCDD, β-Naphthoflavone, Indirubin-3′-oxime, benzo\[a\]pyrene. AhR antagonist had no significant effect on the CYP1A1 expression, such as CH-22319 (Figure [S3](#SM3){ref-type="supplementary-material"}). LPS-induced IL-10 expression levels were similar in ligands-treated and DMSO-treated cells (Figure [3E](#F3){ref-type="fig"}).

![AhR upregulated LPS-induced IL-10 expression in RAW264.7 cells independent of AhR genomic pathway. AhR and Flag protein **(A)** and mRNA **(B)** levels were detected in RAW, RAW/NC, and RAW/AhR cells. The experiment was repeated three times; combined results are compared using one-way ANOVA test (RAW/NC, *P* \< 0.001; RAW/AhR, *P* \< 0.001). **(C,D)** RAW/NC and RAW/AhR cells were stimulated with LPS at the indicated time points. **(C)** IL-10 mRNA levels were detected with qRT-PCR. The experiment was repeated three times; combined results are compared using independent Student\' s *t*-test (*P* = 0.025) **(D)** Supernatants were collected 12 h after LPS stimulation and IL-10 production was measured with ELISA. The experiment was repeated six times; combined results are compared using one-way ANOVA test (*P* = 0.002). **(E)** Peritoneal macrophages were pre-treated with TCDD (1 nM), β-naphthoflavone (1 μM), CH-223191 (10 μM), indirubin-3′-oxime (1 μM), and benzo\[a\]pyrene (10 μM), respectively, for 1 h and then stimulated with or without LPS for 12 h. IL-10 expression was measured with ELISA. **(F)** Schematic of promoter construct of murine *AhR* gene containing 1054 bp upstream of the transcriptional start site cloned into a luciferase reporter vector. Position of the AhR-binding site are presented spanning −631 to −607 bp and −319 to −343 bp. **(G,H)** RAW/NC and RAW/AhR cells were stimulated with or without LPS for 2 h and nuclear-extract proteins were then prepared and incubated with AhR-binding site probe 1 **(G)** and probe 2 **(H)** of the IL-10 promoter. Binding activity was measured using EMSA. **(I)** 293T/NC and 293T/AhR cells were co-transfected with a luciferase reporter gene construct of the murine IL-10 promoter and pRL-TK control plasmids for 48 h. The cells were lysed and luciferase activity was analyzed. AhR and Flag protein levels were detected in 293T/NC and 293T/AhR cells (right). Western blot and EMSA images are representative of three independent experiments. Data in all bar graphs are mean ± SEM of three independent experiments. ^\*^*P* \< 0.05; NS, not significant.](fimmu-09-02033-g0003){#F3}

To examine the effect of AhR on the IL-10 promotor, we constructed a pGL3-Basic-IL10-promoter-luc plasmid spanning −1054 to +10 bp of the IL-10 promotor. Based on the JASPAR database, the AhR binding site was predicted to be the sequence spanning −631 to −607 bp and −319 to −343 bp (Figure [3F](#F3){ref-type="fig"}). Binding of nuclear protein to the AhR-binding site of the IL-10 promotor was detected by electrophoretic mobility shift assay (EMSA). Binding activity levels were similar in RAW/AhR and RAW/NC cells (Figures [3G,H](#F3){ref-type="fig"}). We also established a stable AhR-overexpressing HEK 293T cell line and examined the transcriptional activity of the IL-10 promoter using a luciferase reporter assay. Interestingly, transcriptional activity was also similar in AhR-overexpressing and NC cells (Figure [3I](#F3){ref-type="fig"}). This indicated that the DNA-binding activity and the transcriptional activity of the IL-10 promoter was unaffected by AhR-overexpression. This analysis thus revealed that AhR upregulated LPS-induced IL-10 expression independent of the AhR genomic pathway.

Maximal IL-10 production was associated with STAT3 activation in LPS-induced AhR-overexpressing macrophages
-----------------------------------------------------------------------------------------------------------

STAT3 is a key regulator of LPS-stimulated IL-10 prodution. We therefore determined if STAT3 level and STAT3 phosphorylation were involved in the regulation of IL-10 expression by AhR. Tyrosine phosphorylation of STAT3 was enhanced in RAW/AhR compared with in RAW/NC cells after LPS stimulation, but STAT3 serine phosphorylation of STAT3 was unaffected by AhR (Figures [4A--C](#F4){ref-type="fig"}). Likewise, LPS-stimulated STAT3 phosphorylation was decreased in peritoneal macrophages from AhR-KO mice compared with WT mice (Figure [5I](#F5){ref-type="fig"}). To determine if STAT3 phosphorylation was dependent on IL-10 autocrine secretion by RAW/AhR cells, we pretreated the cells with an IL-10-blocking antibody in the culture medium before LPS stimulation. IL-10 expression was almost undetectable in LPS-induced RAW/AhR cells incubated with an IL-10-blocking antibody, but tyrosine phosphorylation of STAT3 was not dependent on the presence of IL-10 in the culture medium (Figure [4D](#F4){ref-type="fig"}). STAT3 activation appeared to be regulated by the Akt/mTOR/p70S6 and MAPK pathways, but Akt, mTOR and p70S6 levels were unaffected by AhR (Figure [S4B](#SM4){ref-type="supplementary-material"}). There were no significant differences in the main MAPK pathway factors between RAW/NC and RAW/AhR cells (Figure [S4A](#SM4){ref-type="supplementary-material"}). Furthermore, IL-10 expression was unaffected by a MEK inhibitor (Figures S4C,D). We therefore established that STAT3 activation was independent of the Akt/mTOR/p70S6 and MAPK pathways (Figure [S4](#SM4){ref-type="supplementary-material"}).

![Maximal IL-10 production was associated with STAT3-activation in LPS-induced AhR-overexpressing macrophages. RAW/NC and RAW/AhR cells were untreated or treated with LPS. **(A--C)** Cells were stimulated with LPS for 1 h and cell lysates were used for western blotting analysis with anti-phosphotyrosine STAT3, phosphoserine STAT3, STAT3, and AhR antibodies. **(B,C)** Densitometric analysis of relative abundance of phosphotyrosine-STAT3 and phosphoserine-STAT3 normalized to total STAT3. The experiment was repeated three times; combined results are compared using one-way ANOVA test (*P* = 0.020). **(D)** Cells were pre-treated with IL-10-blocking antibody (1 μg/ml) for 12 h and then stimulated with LPS for 1 h, followed by western blotting of whole-cell extracts. **(E,F)** Cells were transfected with scrambled or STAT3-specific siRNA and then incubated with or without LPS for 12 h. Whole-cell lysates were subjected to western blotting analysis. Combined results are compared using one-way ANOVA test (*n* = 3; siSTAT3-1, *P* = 0.015; siSTAT3-2, *P* = 0.039). IL-10 levels in the supernatant were determined with ELISA. Combined results are compared using one-way ANOVA test (*n* = 3; siSTAT3-1, *P* = 0.004; siSTAT3-2, *P* = 0.009). **(G--I)** Cells were pre-treated with two different STAT3 inhibitors (cryptotanshinone and BP-1-102) for 1 h and then stimulated with or without LPS for the indicated times. **(G)** Whole-cell extracts were immunoblotted with anti-phosphotyrosine STAT3 and STAT3 antibodies. **(H)** IL-10 mRNA levels were detected with qRT-PCR. Combined results are compared using one-way ANOVA test (*n* = 3; cryptotanshinone, *P* = 0.017; BP-1-102, *P* = 0.010). **(I)** IL-10 protein levels were detected with ELISA. Combined results are compared using one-way ANOVA test (*n* = 3; cryptotanshinone, *P* = 0.004; BP-1-102, *P* = 0.002). Western blot images are representative of three independent experiments. Data in all bar graphs are mean ± SEM of three independent experiments. Differences were analyzed with one-way ANOVA. ^\*^*P* \< 0.05.](fimmu-09-02033-g0004){#F4}

![AhR upregulated LPS-induced IL-10 expression through Src pathway in macrophages. **(A,B)** RAW/NC and RAW/AhR cells were untreated or treated with LPS for 1 h and cell lysates then subjected to western blotting analysis with anti-phosphotyrosine Src and Src antibodies. **(B)** Densitometric analysis of relative abundances of phospho-Src normalized to total Src. Combined results are compared using one-way ANOVA test (*n* = 3; control, *P* = 0.012; LPS, *P* = 0.039). **(C--F)** Cells were pre-treated with two different Src inhibitors (PP2 and dasatinib) for 1 h and then stimulated with or without LPS for the indicated times. **(C,D)** Whole-cell extracts were immunoblotted with specific antibodies. **(E)** IL-10 mRNA levels were detected with qRT-PCR. Combined results are compared using one-way ANOVA test (*n* = 3; PP2, *P* = 0.015). **(F)** IL-10 protein levels were detected with ELISA. Combined results are compared using one-way ANOVA test (*n* = 3; PP2, *P* = 0.003; dasatinib, *P* = 0.002). **(G,H)** Cells were transfected with scrambled or Src-specific siRNA and then incubated with or without LPS for 12 h. Whole-cell lysates were subjected to western blotting analysis. Combined results are compared using one-way ANOVA test (*n* = 4; siSrc-1, *P* = 0.003; siSrc-2, *P* = 0.004). IL-10 levels in the supernatant were determined with ELISA. Combined results are compared using one-way ANOVA test (n = 3; siSrc-1, *P* = 0.011; siSrc-2, *P* = 0.011). **(I)** Peritoneal macrophages isolated from WT or AhR-KO mice were stimulated with or without LPS for 6 h. Whole-cell lysates were subjected to western blot analysis. Western blot images are representative of three independent experiments. Data in all bar graphs are mean ± SEM of three independent experiments. Differences were analyzed with one-way ANOVA. ^\*^*P* \< 0.05.](fimmu-09-02033-g0005){#F5}

To probe the role of STAT3 in this context, we silenced STAT3 using two different siRNAs (STAT3 siRNA-1 and STAT3 siRNA-2) in RAW/NC and RAW/AhR cells (Figure [4E](#F4){ref-type="fig"}). LPS-induced IL-10 expression was decreased in RAW/AhR cells treated with either STAT3 siRNA compared with cells treated with scrambled siRNA (Figure [4F](#F4){ref-type="fig"}). We also determined if inhibition of STAT3 affected IL-10 production using the STAT3 inhibitors (cryptotanshinone and BP-1-102), which significantly inhibited tyrosine phosphorylation of STAT3 (Figure [4G](#F4){ref-type="fig"}). LPS-stimulated IL-10 mRNA (Figure [4H](#F4){ref-type="fig"}) and protein expression levels (Figure [4I](#F4){ref-type="fig"}) were reduced in RAW/AhR cells treated with STAT3 inhibitor compared with control cells. These results supported our hypothesis that AhR upregulated LPS-induced IL-10 expression via the STAT3 activation.

AhR upregulated LPS-induced IL-10 expression through Src pathway in macrophages
-------------------------------------------------------------------------------

Src kinase is known to mediate the tyrosine-phosphorylation of intracellular target proteins ([@B19]), and its activity is frequently accompanied by AhR activation ([@B9], [@B34]). Notably, Src tyrosine phosphorylation was enhanced in RAW/AhR compared with RAW/NC cells (Figures [5A,B](#F5){ref-type="fig"}). Src activity required AhR, which was necessary for IL-10 expression. Src kinase activity was downregulated by the selective Src inhibitors (PP2 and dasatinib), which significantly inhibited Src tyrosine phosphorylation (Figures [5C,D](#F5){ref-type="fig"}). LPS-stimulated IL-10 mRNA (Figure [5E](#F5){ref-type="fig"}) and protein (Figure [5F](#F5){ref-type="fig"}) were reduced in RAW/AhR cells treated with Src inhibitor compared with control cells. To demonstrate the role of Src in IL-10 expression, we silenced Src in RAW/NC and RAW/AhR cells using two different Src siRNAs (Src siRNA-1 and Src siRNA-2) (Figure [5G](#F5){ref-type="fig"}). LPS-induced IL-10 expression was decreased in RAW/AhR cells treated with either siRNAs compared with cells treated with scrambled siRNA (Figure [5H](#F5){ref-type="fig"}). Notably, STAT3 tyrosine phosphorylation was also inhibited by Src inhibitors, which showed that STAT3 activity was triggered by Src activation (Figures [5C,D](#F5){ref-type="fig"}). Likewise, LPS-stimulated Src phosphorylation was decreased in peritoneal macrophages from AhR-KO mice compared with WT mice (Figure [5I](#F5){ref-type="fig"}). Moreover, we found no direct interaction between AhR and Src-STAT3 in inflammatory macrophages (Figure [S5](#SM5){ref-type="supplementary-material"}). These results indicated that AhR-associated Src activity was responsible for STAT3 phosphorylation and IL-10 production by inflammatory macrophages.

Adoptive transfer of AhR-expressing peritoneal macrophages protected mice against LPS-induced peritonitis
---------------------------------------------------------------------------------------------------------

To enhance the ability of IL-10 production in peritoneal macrophages, the recombinant AhR-expressing adenovirus (Ad-AhR), and negative control adenovirus (Ad-NC) were constructed and transfected into AhR-KO and WT macrophages. The mean fluorescence intensity of FITC was increased in adenovirus-treated cells compared with control cells (Figure [6A](#F6){ref-type="fig"}). Compared with Ad-NC, Ad-AhR significantly improved the phosphorylation of Src and STAT3 in AhR-KO peritoneal macrophages (Figure [6B](#F6){ref-type="fig"}), as well as increased amounts of IL-10 protein (Figure [6C](#F6){ref-type="fig"}). We also found that the levels of AhR, p-Src, and p-STAT3 were enhanced after WT peritoneal macrophages were infected with Ad-AhR compared with Ad-NC (Figure [6D](#F6){ref-type="fig"}). IL-10 protein levels were also increased from Ad-AhR treated group compared with Ad-NC treated group after LPS stimulation (Figure [6E](#F6){ref-type="fig"}). To determine if AhR-expressing PMs could suppress the development of LPS-induced peritonitis, the PMs transfected with Ad-AhR or Ad-NC were adoptively transferred into WT mice after intra-peritoneal injection of LPS (Figure [6F](#F6){ref-type="fig"}). Adoptive transfer of Ad-AhR transfected PMs but not Ad-NC or PBS significantly increased the IL-10 expression and suppressed IL-6 and IL-1β expression in peritoneal lavage fluid from WT peritonitis mice (Figure [6G](#F6){ref-type="fig"}). Furthermore, compared with PBS or Ad-NC, Ad-AhR significantly improved the survival of mice in the lethal LPS-induced peritonitis model (Figure [6H](#F6){ref-type="fig"}). These results demonstrated that the adoptive transfer of AhR-expressing PMs protected mice against LPS-induced peritonitis through high IL-10-production.

![Adoptive transfer of AhR-expressing peritoneal macrophages protected mice against LPS-induced peritonitis. **(A)** Flow cytometry profiles of peritoneal macrophages after 36 h incubation with AhR-overexpressing adenovirus (Ad-AhR) or negative control adenovirus (Ad-NC). **(B--E)** Peritoneal macrophages from AhR-KO **(B,C)** and WT **(D,E)** mice were transfected with Ad-AhR or Ad-NC and then incubated with or without LPS for 12 h. Whole-cell lysates were subjected to western blotting analysis and IL-10 levels in the supernatant were determined with ELISA. Combined results are compared using one-way ANOVA test (*n* = 3; AhR-KO, *P* \< 0.001; WT, *P* = 0.001). **(F)** Peritoneal macrophages transfected with Ad-NC or Ad-AhR were injected intraperitoneally into WT mice at 2 days before the start of LPS treatment. **(G)** Peritoneal lavage fluid was collected from each group at 12 h after LPS stimulation and IL-10 (*n* = 6; *P* \< 0.001), IL-6 (*n* = 6; *P* \< 0.001), and IL-1β (*n* = 6; *P* \< 0.001) protein levels were measured with ELISA.**(H)** Survival rates were monitored for 72 h after LPS stimulation and presented as Kaplan--Meier survival curves. The combined results were analyzed with the log-rank test (*n* = 20; *P* = 0.003). Data in all bar graphs are mean ± SEM of three independent experiments. Differences were analyzed with one-way ANOVA. ^\*^*P* \< 0.05.](fimmu-09-02033-g0006){#F6}

Discussion {#s3}
==========

The results revealed that LPS-induced AhR expression was mediated by the NF-κB pathway in macrophages. Previous data reported that AhR was increased in naïve T cells stimulated by TGF-β plus IL-6, but not by either of these factors alone ([@B31]). AhR was also expressed in BMDCs stimulated by both LPS and CpG ([@B32]). LPS-induced both AhR mRNA and protein expression were increased in human monocyte-derived DC ([@B33]). Besides these cells, we also confirmed that LPS-induced AhR expression was increased in peritoneal macrophages, BMDMs and spleen macrophages. This provides the first evidence for systemic AhR expression in inflammatory macrophages. Furthermore, we demonstrated that LPS-induced AhR expression was disturbed by preincubation of the cells with PDTC, consistent with previous findings showing that the human AhR gene was regulated via the NF-κB signaling pathway ([@B33]). In addition, numerous studies have indicated the physiological role of AhR in limiting the inflammatory response ([@B2], [@B3]). These results provide new insights into that AhR is highly expressed after LPS stimulation in innate immune response, which represents feedback control of the inflammatory response through negative regulation of TLRs signaling pathway by AhR ([@B4], [@B35]).

There is considerable evidence to suggest that AhR signaling is involved in immune system function and recent studies have described a complex interplay between AhR signaling and inflammatory mediators ([@B36], [@B37]). AhR could downregulate the expression of IL-6 ([@B13], [@B14]) and IL-1β ([@B15]) in inflammatory macrophages, in line with our findings. In this study, LPS-induced macrophages isolated from AhR-KO mice shown impaired expression of IL-10, while IL-10 expression was significantly elevated in LPS-induced AhR-overexpressing RAW264.7 cells compared with NC cells. Consistent with our results obtained in mouse inflammatory macrophages, AhR has previously been shown to regulate IL-10 expression in different types of immune cells, including human Treg cells ([@B38]), regulatory type 1 cells ([@B39]), mast cells ([@B40]), and natural killer cells ([@B41]). In the presence of LPS or CpG, AhR-KO mature BMDCs induced immune responses characterized by reduced Kyn and IL-10 production ([@B32]). Additionally, the potent AhR ligand TCDD increased IL-10 expression in LPS-stimulated BMDCs ([@B42], [@B43]), and this effect was suppressed by the AhR antagonist α-naphthoflavone ([@B42]). These findings suggested that AhR was required to induce IL-10 expression in the innate and adaptive immune responses.

To further examine whether AhR modifies macrophage polarization, we evaluate M1/M2 markers in LPS-induced macrophages. AhR-overexpressing cells exhibited a weaker M1 polarization as revealed by cytokines production, and lower levels of IL-1β, IL-6, NOS2, IL-12p40, IL-23 were observed after LPS-mediated activation. As to M2 markers, we only found IL-10 mRNA level was higher in AhR-overexpressing cells. No differences were observed in TNF-α, TGF-β, and Arg1 levels between RAW/NC and RAW/AhR cells. The above data indicate that AhR-overexpressing cells present a mixed response after LPS stimulation. Previous evidence also showed that disruption of the AhR gene alters macrophage polarization to either the M1 or M2 phenotype compared to WT macrophage ([@B44]). These findings showed the important role of AhR in macrophage polarization.

AhR is a ligand-dependent protein activated by a structurally diverse array of ligands. The AhR canonical pathway that is also called as AhR genomic pathway is characterized by AhR nuclear translocation. However, we identified that the AhR chaperone proteins ARNT and HSP90 were not involved in the regulation of inflammatory macrophages, and LPS-induced IL-10 expression was unaffected by most AhR ligands, which bound to AhR to regulate the downstream genomic signaling pathway. Several studies reported that TCDD-driven AhR activation resulted in significantly increased IL-10 expression ([@B38], [@B39], [@B42], [@B43]), and that AhR and ARNT were required for optimal production of IL-10 ([@B41]). However, in the absence of a ligand, we also found that elevated AhR could upregulate LPS-induced IL-10 expression independent of the AhR genomic pathway. The DNA-binding activity at the AhR-binding site of the IL-10 promoter was similar in nuclear extracts from RAW/AhR compared with RAW/NC cells. Interestingly, transcriptional activity was also similar in AhR-overexpressing and NC cells according to a luciferase reporter assay. We demonstrated that AhR did not directly affect the transcriptional activity of L-10 promoter. This suggested that other AhR-associated transcription factors might be implicated in the regulation of IL-10 gene expression in inflammatory macrophages.

Previous evidences showed that STAT3 activation regulated downstream genes by AhR ligands including TCDD ([@B45]), indoxyl sulfate ([@B46]), and β-naphthoflavone ([@B47]). However, the current results showed that ligand-independent activation of AhR could efficiently mobilize LPS-stimulated STAT3. STAT3 protein was phosphorylated at tyrosine, but not at serine, and LPS-stimulated STAT3 phosphorylation was decreased in AhR-KO macrophages. AhR-regulated IL-10 production was attenuated by specific STAT3 inhibitors and siRNAs, suggesting that LPS-induced IL-10 expression was associated with the AhR-STAT3 pathway in macrophages. This was consistent with the finding that AhR cooperated with STAT3 to regulate the differentiation of both Th17 and Treg cells ([@B48]) and the IL-22 promoter in CD4+ T cells ([@B49]). However, immunoprecipitation revealed no direct interaction between AhR and STAT3. Notably, STAT3 has been implicated in the feed-forward loop for IL-10 expression. Our results showed that tyrosine phosphorylation of STAT3 was unaffected by an IL-10-blocking antibody, suggesting that AhR-associated STAT3 activation was independent of autocrine IL-10 signaling. Furthermore, we established that STAT3 activation was independent of the Akt/mTOR/p70S6 and MAPK pathways.

AhR-dependent activation of Src kinase was confirmed in two cell lines ([@B34]), and the importance of Src kinase after AhR-ligands treatment has been in terms of various other effects ([@B50], [@B51]). The present findings suggested that AhR-overexpression was required for tyrosine phosphorylation of Src, and its activity was enhanced in an AhR ligand-independent manner. AhR-KO fibroblasts showed altered FAK phosphorylation and impaired Src activation ([@B52]), in line with our findings indicating that Src kinase activity was influenced by changes in AhR expression levels. In unstimulated cells, Src and AhR coexist in a protein complex that may also contain HSP90, AhR-interacting protein, and P23 ([@B53]). However, we found no direct interaction between AhR and Src in inflammatory macrophages. AhR-regulated IL-10 production was attenuated by specific Src inhibitors and siRNAs, and STAT3 phosphorylation was also inhibited by Src inhibitors, indicating that Src acted upstream of STAT3 in the induction of IL-10. In support of this hypothesis, AF1q-induced platelet-derived growth factor receptor signaling enhanced STAT3 activity through Src kinase activation, which could be blocked by the Src kinase inhibitor PP1 ([@B54]). Moreover, inhibition of Src by PP2 antagonized the activation of STAT3 conferred by GRP78-induced epidermal growth factor signaling ([@B55]). These and our current results suggested that AhR-associated Src activity was responsible for STAT3 phosphorylation and IL-10 production by inflammatory macrophages.

Our results showed that the adoptive transfer of high-IL-10-producing macrophages significantly suppressed the inflammatory response, and improved survival in mice with LPS-induced peritonitis. AhR was previously shown to be involved in the regulation of inflammatory diseases, and accumulating evidence has suggested the existence of multiple crosstalk between AhR and inflammation. AhR-KO mice were hypersensitive to LPS-induced septic shock and showed markedly increased plasma levels of IL-1β, IL-18, IL-6, and TNF-α ([@B8]), and activated AhR was shown to play a central role in limiting endotoxin-triggered inflammation ([@B9]). We speculated that the pathological process might involve a regulatory effect of AhR on IL-10. Intriguingly, we found that adoptive transfer of AhR-expressing PMs protected mice against LPS-induced peritonitis via increased IL-10-production. These results strongly indicate that AhR enhances IL-10 production by macrophages, resulting in suppression of the inflammatory response. Further studies will be needed to investigate the effect of AhR on IL-10 in other inflammatory diseases.

This study had some limitations. Although we established that LPS-induced AhR expression was increased by the NF-κB pathway in macrophages, it remains unclear if AhR is also highly expressed after stimulation by other TLR-ligands in the innate immune response. Furthermore, we showed that AhR regulated IL-10 expression through a non-genomic pathway associated with Src- and STAT3-activation, but the details of this interaction remain to be fully characterized. Further studies are needed to track the location of AhR and detect the AhR-interacting proteins. It is also possible that mechanisms other than the Src-STAT3 signaling pathway may be involved in regulating IL-10 expression in other situations, and more studies are required to clarify this. Nevertheless, the present results provide valuable information about the crosstalk between AhR and IL-10 expression in macrophages and establish an innovative platform for future studies of the mechanisms of AhR in immune regulation.

In the current study, we showed that AhR was markedly increased in LPS-stimulated macrophages, and found that AhR positively regulated the expression of IL-10 in macrophages and RAW264.7 cells. Maximal LPS-stimulated IL-10 production was associated with Src and STAT3 activation, but not via the ligand activation and the AhR genomic pathway. Furthermore, AhR-associated Src activity was responsible for tyrosine phosphorylation of STAT3 and IL-10 expression in inflammatory macrophages (Figure [7](#F7){ref-type="fig"}). In conclusion, our results indicate that the AhR-Src-STAT3-IL-10 signaling pathway is a critical pathway involved in the immune regulation of inflammatory macrophages and suggest that AhR may be a potential therapeutic target in immune response. Further understanding and rational utilization of this signaling pathway may help in the establishment of effective therapies for inflammatory diseases.

![Proposed network for AhR-Src-STAT3-IL-10 signaling pathway in inflammatory macrophages. AhR expression is highly enhanced in LPS-induced inflammatory macrophages via the NF-κB pathway. AhR binds to the IL-10-promoter, but does not affect the transcriptional activity of IL-10. Increased AhR in the cytoplasm upregulates the tyrosine phosphorylation of Src, which can be suppressed by selective Src inhibitors (PP2 and dasatinib). STAT3 is also activated by phosphorylation of tyrosine 705, triggered by Src tyrosine kinase and suppressed by selective STAT3 inhibitors (cryptotanshinone and BP-1-102). STAT3 activation is independent of IL-10 autocrine feedback, Akt/mTOR, and MAPK pathways. The activated signaling pathway promotes LPS-induced IL-10 expression. Overall, AhR-associated Src activity is responsible for the tyrosine phosphorylation of STAT3 and IL-10 expression in LPS-induced inflammatory macrophages.](fimmu-09-02033-g0007){#F7}

Materials and methods {#s4}
=====================

Materials
---------

LPS (Escherichia coli 0111: B4), TCDD, β-naphthoflavone, CH-223191, indirubin-3′-oxime, and benzo\[a\]pyrene were purchased from Sigma-Aldrich. PE anti-mouse F4/80 Antibody (123110), FITC anti-mouse/human CD11b Antibody (101206) and LEAF™-Purified anti-mouse IL-10-blocking Antibody (JES5-16E3) were obtained from Biolegend. The NF-κB inhibitor PDTC, STAT3 inhibitors cryptotanshinone and BP-1-102, the Src inhibitors PP2 and dasatinib, and MEK inhibitor PD98059 were purchased from Selleck. Penicillin, streptomycin, RPMI 1640 and fetal bovine serum were produced by Gibco-BRL Invitrogen.

Macrophage preparation and cell culture
---------------------------------------

Peritoneal macrophages were obtained from mice by flushing the peritoneal cavity with 5 ml PBS 4 days after intraperitoneal injection of 4% thioglycollate. The peritoneal exudate cells were centrifuged (300 × g) and adhered to the Petri dish for 2 h at 37°C. Non-adherent cells were removed by gently washing three times with warm PBS, and peritoneal macrophages were then harvested from the adherent cells. Murine bone marrow cells were obtained from mice and differentiated into mature macrophages during 7 days culture in murine complete medium supplemented with GM-CSF (25 ng/ml; Miltenyi Biotec). BMDMs were harvested from the adherent cells. Isolated spleens were ground in saline solution using a glass homogenizer and the cell suspension was passed through cell strainer (70 μm; Corning). The resulting suspension of splenocytes was centrifuged (300 × g, 5 min) and resuspended in red cell lysis buffer (Tiangen) for 5 min. The cell suspension was then incubated in the Petri dish for 2 h at 37°C. The cell monolayer was flushed with PBS to remove attendant lymphocytes, fibroblasts, and erythrocytes. Spleen macrophages were obtained using a scraper and used for further experiments.

RAW264.7 cells (ATCC®-TIB-71™) and HEK 293T cells (ATCC®-CRL-11268™) were maintained in RPMI1640 and DMEM medium, respectively, supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 10% FBS. The cells were grown at 37°C and 5% CO~2~ in humidified air. RAW264.7 cells and 293T cells were stably transfected with recombinant lentivirus containing the whole coding sequence of AhR-EGFP (GeneChem). The stable AhR-overexpressing RAW264.7 cell line (RAW/AhR) and normal control cell line (RAW/NC) were maintained in the presence of 2 μg/ml puromycin.

Mice
----

All animal experiments were carried out in accordance with the recommendations of the guidelines for Care and Use of Laboratory Animals of the National Institutes of Health, and the following animal protocol was approved by the intramural Committee on Ethics Conduct of Animal Studies of the Army Medical University. AhR+/− mice lacking exon 2 on a C57BL/6 background were purchased from the Jackson Laboratory. AhR+/+ and AhR−/− mice were bred from AhR+/− mice and maintained as separate colonies. C57BL/6 mice (8--10 weeks old, 18--22 g) were purchased from the Experimental Animal Center of Army Medical University (Chongqing, China).

Flow cytometry
--------------

Peritoneal macrophages, BMDMs and spleen macrophages were isolated from mice and were prepared for single-cell suspensions. The cells were stained with conjugated fluorescent antibodies at predetermined optimum concentrations (anti-F4/80-PE and anti-CD11b-FITC) and incubate on ice for 20 min in the dark. After washing and centrifugation, the cells were resuspended in PBS and subjected to flow cytometric analysis.

Elisa
-----

Supernatants were collected from treated cells and peritoneal lavage fluid and stored at −80°C until analysis. Expression levels of IL-10, IL-6, and IL-1β were assessed using ELISA kits (Boster). The absorbance was measured at 450 nm.

Quantitative reverse transcription PCR analysis
-----------------------------------------------

Total RNA was extracted using TRIzol reagent (Invitrogen). Complementary DNA was synthesized from 1 μg of total RNA by reverse transcription, and the mRNAs of interest were quantitated by qRT-PCR analysis using SYBR Premix (TaKaRa) on a BioRad CFX96. β-actin was chosen as the reference gene (Table [1](#T1){ref-type="table"}).

###### 

Primers used to amplify mRNAs via qRT-PCR.

  **Gene**   **Forward primer (5^′^-3^′^)**   **Reverse primer (5^′^-3^′^)**
  ---------- -------------------------------- --------------------------------
  AhR        CAAATCCTTCTAAGCGACACAG           TGACGCTGAGCCTAAGAACA
  IL-10      GCTCTTACTGACTGGCATGAG            CGCAGCTCTAGGAGCATGTG
  IL-6       ACCACGGCCTTCCCTACTTC             CTCATTTCCACGATTTCCCAG
  IL-1β      GCAACTGTTCCTGAACTCAACT           ATCTTTTGGGGTCCGTCAACT
  TNF-α      GAGTCCGGGCAGGTCTACTTT            CAGGTCACTGTCCCAGCATCT
  TGF-β      CACAGAGAAGAACTGCTGTG             AGGAGCGCACAATCATGTTG
  CYP1A1     GCAATGAGTTTGGGGAGGT              AAGGCATCCAGGGAAGAGTT
  IL-12p40   TGGTTTGCCATCGTTTTGCTG            ACAGGTGAGGTTCACTGTTTCT
  IL-23      ATGCTGGATTGCAGAGCAGTA            ACGGGGCACATTATTTTTAGTCT
  NOS2       GTTCTCAGCCCAACAATACAAGA          GTGGACGGGTCGATGTCAC
  Arg1       GAGATTCCTGAAACCGAACCTC           ACTACAGGGATTACTGTCGAGG
  β-actin    AGCCATGTACGTAGCCATCC             CTCTCAGCTGTGGTGGTGAA

Luciferase reporter assay
-------------------------

HEK 293T cells were co-transfected with 1 μg of pGL3-Basic-IL10-promoter-luc and 0.1 μg of pRL-TK plasmid (Fitgene Biotech) for 48 h using Lipofectamine 2000 transfection reagent (Invitrogen). The cells were then lysed and detected using dual luciferase reporter gene assay kit (Beyotime). IL-10 transcription activity was defined as the percentage of relative light units of firefly luciferase to *Renilla* luciferase.

EMSA
----

Nuclear extracts from treated RAW 264.7 cells were prepared using a nuclear and cytoplasmic protein extraction kit (Beyotime) and quantified. Binding activity between nuclear proteins and the AhR-binding site of the *IL-10* promoter was assessed by electrophoresis of the DNA--protein complexes on a 6% polyacrylamide native gel for 40 min at 180 V, followed by detection at 700 nm using the Odyssey scanning bed (LiCor). The probes labeled infrared ray 700 (Viagene Biotech), containing the consensus recognition site for AhR, were as follows: AhR1 forward: 5′- GCTTCTT[CGTG]{.ul}AAA[CACG]{.ul}GGGCAGA-3′; AhR1 reverse: 5′- TCTGCCC[CGTG]{.ul}TTT[CACG]{.ul}AAGAAGC-3′; AhR2 forward: 5′- GACCTGGGAG[TGCGTG]{.ul}AATGGAATC-3′; AhR2 reverse: 5′-GATTCCATT[CACGCA]{.ul}CTCCCAGGTC-3′.

Western blotting
----------------

Cells were lysed in lysis buffer (50 mM Tris-HCl \[pH 7.5\], 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 0.5 mM Na~3~VO~4~, 50 mM NaF, 1 mM PMSF, and protease inhibitor cocktail \[Beyotime\]) for 30 min on ice. Cell debris was removed by centrifugation at 12,000 × g for 15 min at 4°C. Protein concentrations in the cell lysates were determined using a BCA protein assay kit (Beyotime). An equal amount of protein for each sample was separated on 10% Tris-Glycine extended stain-free polyacrylamide gels (Bio-Rad) and the loading control was measured by imaging of the stain-free gel. Total protein stains were used as loading control for quantitative protein analysis. SDS gels were then transferred to polyvinylidene difluoride membranes (Millipore), blocked with 5% skim milk for 1 h in Tris buffered saline contained 0.1% Tween 20, and incubated with the indicated primary antibodies overnight at 4°C. The next day, the membranes were washed and probed for 1 h with the respective HRP-conjugated secondary antibody (Cell Signaling Technology). The immunoreactive bands were detected using an enhanced chemiluminescence detection system (Bio-Rad), and the band intensities were measured by densitometric analysis using Image J software. Anti-AhR (BML-SA210) antibody was purchased from Enzo Life, and antibodies against HSP90 (4877), ARNT (5537), FLAG (14793), β-actin (4970), serine-phosphorylated STAT3 (9134), tyrosine-phosphorylated STAT3 (9145), total STAT3 (4904), tyrosine-phosphorylated Src (6943), total Src (2109), p65 (8242), p50 (12540), mTOR (2972), phospho-mTOR (2971), p70S6 (2708), phospho-p70S6 (9204), Akt (9272), total ERK1/2 (4695) and phospho-Erk1/2 pathway sampler kit (9911) were obtained from Cell Signaling Technology.

Immunofluorescence and confocal analysis
----------------------------------------

The cells on coverslips (Nest) were fixed with 4% paraformaldehyde (Beyotime) in PBS for 30 min at room temperature, permeabilized with 0.5% Triton X-100 (Beyotime) in PBS for 10 min at room temperature, and then blocked with PBS containing 1% BSA and 1% goat serum for 30 min. The cells on coverslips were incubated with primary antibody to AhR (1:100, sc-8088, Santa Cruz) at 4°C overnight, followed by Alexa Fluor 594-conjugated donkey anti-goat IgG (1:200, Invitrogen) in the dark for 1 h in PBS containing 1% BSA and 0.5% Triton X-100, followed by DAPI (Beyotime) for 10 min. All incubations were performed followed by three washes with PBS. Coverslips were mounted with antifade mounting medium (Beyotime), placed on glass slides, and imaged using a LSM 780 laser-scanning confocal microscope (Carl Zeiss).

RNA interference
----------------

STAT3-specific, Src-specific, and scrambled control siRNAs were obtained from Ribobio. Cells were plated at a density of 2 × 10^5^ cells per well on six-well plates and transfected with 100 nM of STAT3-specific, Src-specific, or scrambled control siRNA in riboFECT™ CP Reagent (Ribobio). Six hours after transfection, siRNA and oligofectamine mixtures were discarded and substituted with RPMI 1640 containing 10% serum, and then incubated with or without LPS for 12 h. Cell lysate and supernatant were collected for analysis 72 h after transfection for analysis. The following siRNA sequences were used: STAT3 siRNA-1: 5′-CCACGTTGGTGTTTCATAA-3′; STAT3 siRNA-2: 5′-GCAGGATCTAGAACAGAAA-3′; Src siRNA-1: 5′-GGCTGCAGATTGTCAATAA-3′; Src siRNA-2: 5′-GCCTCTCTGTATCCGACTT-3′.

Inhibitor assay
---------------

RAW cells (2 × 10^6^ cells/well) were cultured in six-well plates for 12 h and pre-treated with or without cryptotanshinone (10 μM), BP-1-102 (5 μM), PP2 (5 μM), dasatinib (1 μM), and PD98059 (10 μM), respectively, for 1 h. The cells were then stimulated with or without LPS (10 μg/ mL) for the indicated times. Cell lysates were collected for western blotting analysis. IL-10 mRNA and protein levels were detected with qRT-PCR and ELISA, respectively.

Infection of macrophages with recombinant AhR adenovirus
--------------------------------------------------------

Recombinant adenovirus containing the gene coding full-length mouse AhR and control adenovirus containing the enhanced GFP gene were obtained from Hanbio Biotechlogy. Recombinant AhR adenovirus infection of peritoneal macrophages were carried out at MOIs of 1000 for 6 h, then cultured for 36 h in fresh medium. The control adenovirus was used as negative control. Twenty-four hours after viral infection, the macrophages were treated with LPS for 12 h and collected for flow cytometry analysis.

LPS-induced peritonitis model
-----------------------------

To induce acute peritonitis, mice were injected intraperitoneally with 10 mg/kg LPS. The transfected PMs (2 × 10^6^) were injected intraperitoneally into WT mice 2 days before LPS-induced peritonitis. The treated mice were sacrificed at 12 h after LPS injection and peritoneal lavage fluid was prepared by a single washing of the peritoneal cavity with 3 ml PBS at 4°C. The IL-10, IL-6, and IL-1β protein concentrations in the peritoneal lavage fluid were quantified with ELISA. In the survival studies, the mice were injected with 20 mg/kg LPS intraperitoneally and were observed for 3 days.

Statistical analysis
--------------------

Data were presented as mean ± standard error (SEM). Statistical analyses were performed using one-way ANOVA followed by LSD multiple-comparison test. Survival rates were analyzed using the Mantel--Cox test. All statistical analyses were performed using SPSS 16.0 (SPSS Inc.) or Prism 6.0 (GraphPad Inc.) software, and values of *P* \< 0.05 were considered statistically significant.
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AhR

:   aryl hydrocarbon receptor

ARNT

:   AhR nuclear translocator

BMDM

:   bone marrow derived macrophage

DC

:   dendritic cell

EMSA

:   electrophoretic mobility shift assay

HSP90

:   heat shock protein 90

NC

:   normal control

PDTC

:   pyrrolidinedithiocarbamate

PM

:   peritoneal macrophage

TCDD, 2, 3, 7

:   8-tetrachlorodibenzo p-dioxin.

[^1]: Edited by: Philippe Saas, INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, France

[^2]: Reviewed by: Elodie Segura, Institute Curie, France; Yuji Naito, Kyoto Prefectural University of Medicine, Japan

[^3]: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
